Company intelligence / Profile preview

RxHearing Aids

United States

Ownership: Private
Development stage: Other

Overview

RxHearing offers FDA-registered over-the-counter hearing aids designed for mild to moderate hearing loss, focusing on affordability and accessibility. Their devices are available in over 200 independent pharmacies across 44 states, backed by licensed hearing specialists and audiologists. Clinical efficacy data is not published, but devices are FDA-registered, and the company reports positive customer outcomes and high adoption rates.[1][2][3][5]

Therapeutic areas: Neurology
Modalities: Device
Industry: Assistive Medical Devices

Partnerships

American Pharmacy Cooperative, Inc. (APCI)Seniors Blue Book

Beyond the preview

Go deeper on RxHearing Aids.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxHearing Aids.

Explore the full profile